1. Home
  2. MDXG vs HQH Comparison

MDXG vs HQH Comparison

Compare MDXG & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • HQH
  • Stock Information
  • Founded
  • MDXG 2006
  • HQH 1986
  • Country
  • MDXG United States
  • HQH United States
  • Employees
  • MDXG N/A
  • HQH N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • HQH Finance Companies
  • Sector
  • MDXG Health Care
  • HQH Finance
  • Exchange
  • MDXG Nasdaq
  • HQH Nasdaq
  • Market Cap
  • MDXG 1.0B
  • HQH 890.9M
  • IPO Year
  • MDXG N/A
  • HQH N/A
  • Fundamental
  • Price
  • MDXG $7.27
  • HQH $18.48
  • Analyst Decision
  • MDXG Buy
  • HQH
  • Analyst Count
  • MDXG 1
  • HQH 0
  • Target Price
  • MDXG $12.00
  • HQH N/A
  • AVG Volume (30 Days)
  • MDXG 650.1K
  • HQH 183.8K
  • Earning Date
  • MDXG 10-29-2025
  • HQH 01-01-0001
  • Dividend Yield
  • MDXG N/A
  • HQH 11.56%
  • EPS Growth
  • MDXG N/A
  • HQH N/A
  • EPS
  • MDXG 0.21
  • HQH 1.09
  • Revenue
  • MDXG $363,774,000.00
  • HQH N/A
  • Revenue This Year
  • MDXG $12.68
  • HQH N/A
  • Revenue Next Year
  • MDXG $8.18
  • HQH N/A
  • P/E Ratio
  • MDXG $34.82
  • HQH $15.24
  • Revenue Growth
  • MDXG 6.85
  • HQH N/A
  • 52 Week Low
  • MDXG $5.47
  • HQH $14.31
  • 52 Week High
  • MDXG $10.14
  • HQH $17.94
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 56.76
  • HQH 72.67
  • Support Level
  • MDXG $6.62
  • HQH $18.25
  • Resistance Level
  • MDXG $7.04
  • HQH $18.79
  • Average True Range (ATR)
  • MDXG 0.23
  • HQH 0.28
  • MACD
  • MDXG 0.02
  • HQH 0.11
  • Stochastic Oscillator
  • MDXG 86.52
  • HQH 86.20

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About HQH abrdn Healthcare Investors Shares of Beneficial Interest

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Share on Social Networks: